The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Mechanism of Uptake and Incorporation of the Non-human Sialic Acid N-Glycolylneuraminic Acid into Human Cells*
Open accessAbstract
N-Glycolylneuraminic acid (Neu5Gc) is a widely expressed sialic acid in mammalian cells. Although humans are genetically deficient in producing Neu5Gc, small amounts are present in human cells in vivo. A dietary origin was suggested by human volunteer studies and by observing that free Neu5Gc is metabolically incorporated into cultured human carcinoma cells by unknown mechanisms. We now show that free Neu5Gc uptake also occurs in other human and mammalian cells. Inhibitors of certain non-clathrin-mediated endocytic pathways reduce Neu5Gc accumulation. Studies with human mutant cells show that the lysosomal sialic acid transporter is required for metabolic incorporation of free Neu5Gc. Incorporation of glycosidically bound Neu5Gc from exogenous glycoconjugates (relevant to human gut epithelial exposure to dietary Neu5Gc) requires the transporter as well as the lysosomal sialidase, which presumably acts to release free Neu5Gc. Thus, exogenous Neu5Gc reaches lysosomes via pinocytic/endocytic pathways and is exported in free form into the cytosol, becoming available for activation and transfer to glycoconjugates. In contrast, N-glycolylmannosamine (ManNGc) apparently traverses the plasma membrane by passive diffusion and becomes available for conversion to Neu5Gc in the cytosol. This mechanism can also explain the metabolic incorporation of chemically synthesized unnatural sialic acids, as reported by others. Finally, to our knowledge, this is the first example of delivery to the cytosol of an extracellular small molecule that cannot cross the plasma membrane, utilizing fluid pinocytosis and a specific lysosomal transporter. The approach could, thus, potentially be generalized to any small molecule that has a specific lysosomal transporter but not a plasma membrane transporter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bertozzi, C. R., & Kiessling, A. L. L. (2001) · Science · doi:10.1126/science.1059820 · Cited by 1,939
Maxfield, F. R., & McGraw, T. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1315 · Cited by 1,729
Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective
Angata, T., & Varki, A. (2002) · Chemical Reviews · doi:10.1021/cr000407m · Cited by 1,237
Self-citationSchnitzer, J. E., Oh, P., Pinney, E., & Allard, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.5.1217 · Cited by 919
Chemical remodelling of cell surfaces in living animals
Prescher, J. A., Dube, D. H., & Bertozzi, C. R. (2004) · Nature · doi:10.1038/nature02791 · Cited by 842
Swanson, J. A., & Watts, C. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)89101-1 · Cited by 733
Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid
Tangvoranuntakul, P., Gagneux, P., Diaz, S., Bardor, M., Varki, N., Varki, A., & Muchmore, E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2131556100 · Cited by 625
Self-citationVarki, A. (1992) · Glycobiology · doi:10.1093/glycob/2.1.25 · Cited by 602
Self-citationA mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence
Chou, H.-H., Takematsu, H., Diaz, S., Iber, J., Nickerson, E., Wright, K. L., Muchmore, E. A., Nelson, D. L., Warren, S. T., & Varki, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11751 · Cited by 575
Self-citationSialic acids as ligands in recognition phenomena
Varki, A. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.4.9068613 · Cited by 536
Self-citation
Cited by
Sialic acids in human health and disease
Varki, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.002 · Cited by 999
Self-citationHuman embryonic stem cells express an immunogenic nonhuman sialic acid
Martin, M. J., Muotri, A., Gage, F., & Varki, A. (2005) · Nature Medicine · doi:10.1038/nm1181 · Cited by 932
Self-citationSialic acids in cancer biology and immunity
Pearce, O. M. T., & Läubli, H. (2016) · Glycobiology · doi:10.1093/glycob/cwv097 · Cited by 470
Estrada, J. L., Martens, G., Li, P., Adams, A., Newell, K. A., Ford, M. L., Butler, J. R., Sidner, R., Tector, M., & Tector, J. (2015) · Xenotransplantation · doi:10.1111/xen.12161 · Cited by 417
Fc glycans of therapeutic antibodies as critical quality attributes
Reusch, D., & Tejada, M. L. (2015) · Glycobiology · doi:10.1093/glycob/cwv065 · Cited by 404
Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
Ghaderi, D., Taylor, R. E., Padler-Karavani, V., Diaz, S., & Varki, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1651 · Cited by 372
Self-citationSialic Acid Is an Essential Nutrient for Brain Development and Cognition
Wang, B. (2009) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155515 · Cited by 362
Padler-Karavani, V., Yu, H., Cao, H., Chokhawala, H., Karp, F., Varki, N., Chen, X., & Varki, A. (2008) · Glycobiology · doi:10.1093/glycob/cwn072 · Cited by 326
Self-citationGhaderi, D., Zhang, M., Hurtado-Ziola, N., & Varki, A. (2012) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-28-147 · Cited by 320
“Similar accumulation takes place in the human body due to exogenous Neu5Gc derived from foods of mammalian origin (in particular, red meats) (Tangvoranuntakul et al., 2003; Bardor et al., 2005).”
BackgroundInfluentialSelf-citationRecent Advances on Structure, Metabolism, and Function of Human Milk Oligosaccharides
Bode, L. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.8.2127 · Cited by 311
Metabolic glycoengineering: Sialic acid and beyond
Du, J., Meledeo, M. A., Wang, Z., Khanna, H. S., Paruchuri, V. D. P., & Yarema, K. J. (2009) · Glycobiology · doi:10.1093/glycob/cwp115 · Cited by 299
Uniquely human evolution of sialic acid genetics and biology
Varki, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914634107 · Cited by 278
Self-citationGlycointeractions in bacterial pathogenesis
Poole, J., Day, C. J., von Itzstein, M., Paton, J. C., & Jennings, M. P. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0007-2 · Cited by 271
Molecular basis of the structure and function of H1 hemagglutinin of influenza virus
SRIWILAIJAROEN, N., & SUZUKI, Y. (2012) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.88.226 · Cited by 270
North, S. J., Huang, H.-H., Sundaram, S., Jang-Lee, J., Etienne, A. T., Trollope, A., Chalabi, S., Dell, A., Stanley, P., & Haslam, S. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068353 · Cited by 207
Involvement of a Non-Human Sialic Acid in Human Cancer
Samraj, A. N., Läubli, H., Varki, N., & Varki, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00033 · Cited by 196
Self-citationMartin, M. J., Rayner, J. C., Gagneux, P., Barnwell, J. W., & Varki, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503819102 · Cited by 193
Self-citationHuman cells: new platform for recombinant therapeutic protein production
Swiech, K., Picanço-Castro, V., & Covas, D. T. (2012) · Protein Expression and Purification · doi:10.1016/j.pep.2012.04.023 · Cited by 178
Potential impact of the non‐human sialic acid N‐glycolylneuraminic acid on transplant rejection risk
Padler‐Karavani, V., & Varki, A. (2011) · Xenotransplantation · doi:10.1111/j.1399-3089.2011.00622.x · Cited by 162
“In this regard, Neu5Gc can be taken up by cultured human cells in vitro from Neu5Gc-containing media supplements like fetal calf serum (FCS), and, being compatible with intrinsic human biochemical pathways, it is metabolically incorporated, resulting in its cell surface expression [13].”
BackgroundSelf-citationAlisson-Silva, F., Kawanishi, K., & Varki, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.07.002 · Cited by 156
Self-citationAbsence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans—An Evolutionary Perspective
Altman, M. O., & Gagneux, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00789 · Cited by 112
Kawanishi, K., Dhar, C., Do, R., Varki, N., Gordts, P. L. S. M., & Varki, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902902116 · Cited by 94
Self-citationPotential deleterious role of anti‐Neu5Gc antibodies in xenotransplantation
Salama, A., Evanno, G., Harb, J., & Soulillou, J. (2015) · Xenotransplantation · doi:10.1111/xen.12142 · Cited by 81
Why Is N-Glycolylneuraminic Acid Rare in the Vertebrate Brain?
Davies, L. R. L., & Varki, A. (2013) · Topics in Current Chemistry · doi:10.1007/128_2013_419 · Cited by 80
Self-citationGlycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
Yehuda, S., & Padler-Karavani, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00021 · Cited by 71
The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation
Tector, A. J., Mosser, M., Tector, M., & Bach, J.-M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00622 · Cited by 60
Barnard, K. N., Wasik, B. R., LaClair, J. R., Buchholz, D. W., Weichert, W. S., Alford-Lawrence, B. K., Aguilar, H. C., & Parrish, C. R. (2019) · mBio · doi:10.1128/mbio.02490-19 · Cited by 57
Picanco-Castro, V., Biaggio, R., Cova, D., & Swiech, K. (2013) · Protein & Peptide Letters · doi:10.2174/092986652012131112130322 · Cited by 34
Lee, J.-G., Lee, S., Jeon, J., Kong, H. G., Cho, H.-J., Kim, J.-H., Kim, S.-Y., Oh, M. J., Lee, D., Seo, N., et al. (2022) · Microbiome · doi:10.1186/s40168-021-01191-x · Cited by 26
Human neuraminidases have reduced activity towards modified sialic acids on glycoproteins
Hunter, C. D., Porter, E. M., & Cairo, C. W. (2020) · Carbohydrate Research · doi:10.1016/j.carres.2020.108139 · Cited by 13
Metadata
- Authors
- Bardor, M., Nguyen, D. H., Diaz, S., & Varki, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 280
- Issue
- 6
- Pages
- 4228-4237
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2120533079
- Cited by
- 390
- References
- 65
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.